Frost & Sullivan
Officials from Frost & Sullivan report latest developments
Published in Lab Business Week, January 14th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Frost & Sullivan.
Report 1: Biopharmaceutical products are considerably more expensive than traditional ones, largely due to the high-cost technology required for production.
Apart from the various investments in the development and registration of new drugs, meeting regulatory specifications can take 6-12 years and the entire product launch can cost $200-500 million, according to research from Frost & Sullivan.
To successfully introduce drugs, product...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-01-14)
More Articles from Lab Business Week
- Antisense Technology
Research from Abbott Laboratories in antisense technology provides new insights - Business Update
Barr confirms generic Thalomid capsule application - Business Update
Paladin, Auxilium sign exclusive distribution agreement for Testim - Cell Biology
Cold Spring Harbor Laboratory describes research in cell biology - Depression
New findings from Pelvipharm Laboratories in the area of depression published - Depression
Research findings from Cold Spring Harbor Laboratory update understanding of depression - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
